Skip navigation
  • Sciety Labs đź§Ş (Experimental)
  • Search
Sciety application utilities

Infectious Diseases (except HIV/AIDS)

  • Subscribe to feed (RSS)

Showing page 208 of 716 pages of list content

  • Comparative study of immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in Belarus

    This article's authors
    1. Igor Stoma
    2. Katsiaryna Korsak
    3. Evgenii Voropaev
    4. Olga Osipkina
    5. Aleksey Kovalev
    This article has 1 evaluations Latest evaluation on Feb 9, 2022 Published on Feb 6, 2022
  • Estimation and interpretation of vaccine efficacy in COVID-19 randomized clinical trials

    This article's authors
    1. Hege Michiels
    2. An Vandebosch
    3. Stijn Vansteelandt
    This article has 1 evaluations Latest evaluation on Feb 8, 2022 Published on Feb 5, 2022
  • Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

    This article's authors
    1. Anh Duc Dang
    2. Thiem Dinh Vu
    3. Ha Hai Vu
    4. Van Thanh Ta
    5. Anh Thi Van Pham
    6. Mai Thi Ngoc Dang
    7. Be Van Le
    8. Thai Huu Duong
    9. Duoc Van Nguyen
    10. Saranath Lawpoolsri
    11. Pailinrut Chinwangso
    12. Jason S. McLellan
    13. Ching-Lin Hsieh
    14. Adolfo Garcia-Sastre
    15. Peter Palese
    16. Weina Sun
    17. Jose L. Martinez
    18. Irene Gonzalez-Dominguez
    19. Stefan Slamanig
    20. Juan Manuel Carreño
    21. Johnstone Tcheou
    22. Florian Krammer
    23. Ariel Raskin
    24. Huong Minh Vu
    25. Thang Cong Tran
    26. Huong Mai Nguyen
    27. Laina D. Mercer
    28. Rama Raghunandan
    29. Manjari Lal
    30. Jessica A. White
    31. Richard Hjorth
    32. Bruce L. Innis
    33. Rami Scharf
    This article has 1 evaluations Latest evaluation on Feb 8, 2022 Published on Feb 5, 2022
  • Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19

    This article's authors
    1. Charles W. Bishop
    2. Akhtar Ashfaq
    3. Joel Z. Melnick
    4. Enrique Vazquez-Escarpanter
    5. Jonathan A. Fialkow
    6. Stephen A. Strugnell
    7. John Choe
    8. Kamyar Kalantar-Zadeh
    9. Noah C. Federman
    10. David Ng
    11. John S. Adams
    This article has 1 evaluations Latest evaluation on Feb 8, 2022 Published on Feb 5, 2022
  • COMPARATIVE PERFORMANCE OF TWO AUTOMATED MACHINE LEARNING PLATFORMS FOR COVID-19 DETECTION BY MALDI-TOF-MS

    This article's authors
    1. Hooman H. Rashidi
    2. John Pepper
    3. Taylor Howard
    4. Karina Klein
    5. Larissa May
    6. Samer Albahra
    7. Brett Phinney
    8. Michelle R. Salemi
    9. Nam K. Tran
    This article has 1 evaluations Latest evaluation on Feb 8, 2022 Published on Feb 4, 2022
  • SurvMaximin: Robust Federated Approach to Transporting Survival Risk Prediction Models

    This article's authors
    1. Xuan Wang
    2. Harrison G Zhang
    3. Xin Xiong
    4. Chuan Hong
    5. Griffin M Weber
    6. Gabriel A Brat
    7. Clara-Lea Bonzel
    8. Yuan Luo
    9. Rui Duan
    10. Nathan P Palmer
    11. Meghan R Hutch
    12. Alba Gutiérrez-Sacristán
    13. Riccardo Bellazzi
    14. Luca Chiovato
    15. Kelly Cho
    16. Arianna Dagliati
    17. Hossein Estiri
    18. Noelia GarcĂ­a-Barrio
    19. Romain Griffier
    20. David A Hanauer
    21. Yuk-Lam Ho
    22. John H Holmes
    23. Mark S Keller
    24. Jeffrey G Klann
    25. Sehi L’Yi
    26. Sara Lozano-Zahonero
    27. Sarah E Maidlow
    28. Adeline Makoudjou
    29. Alberto Malovini
    30. Bertrand Moal
    31. Jason H Moore
    32. Michele Morris
    33. Danielle L Mowery
    34. Shawn N Murphy
    35. Antoine Neuraz
    36. Kee Yuan Ngiam
    37. Gilbert S Omenn
    38. Lav P Patel
    39. Miguel Pedrera-Jiménez
    40. Andrea Prunotto
    41. Malarkodi Jebathilagam Samayamuthu
    42. Fernando J Sanz Vidorreta
    43. Emily R Schriver
    44. Petra Schubert
    45. Pablo Serrano-Balazote
    46. Andrew M South
    47. Amelia LM Tan
    48. Byorn W.L. Tan
    49. Valentina Tibollo
    50. Patric Tippmann
    51. Shyam Visweswaran
    52. Zongqi Xia
    53. William Yuan
    54. Daniela Zöller
    55. Isaac S Kohane
    56. The Consortium for Clinical Characterization of COVID-19 by EHR (4CE)
    57. Paul Avillach
    58. Zijian Guo
    59. Tianxi Cai
    This article has 1 evaluations Latest evaluation on Feb 8, 2022 Published on Feb 4, 2022
  • Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19

    This article's authors
    1. Adeola Fowotade
    2. Folasade Bamidele
    3. Boluwatife Egbetola
    4. Adeniyi Francis Fagbamigbe
    5. Babatunde Ayodeji Adeagbo
    6. Bolanle Olufunlola Adefuye
    7. Ajibola Olagunoye
    8. Temitope Olumuyiwa Ojo
    9. Akindele Olupelumi Adebiyi
    10. Omobolanle Ibitayo Olagunju
    11. Olabode Taiwo Ladipo
    12. Abdulafeez Akinloye
    13. Adedeji Onayade
    14. Oluseye Oladotun Bolaji
    15. Steve Rannard
    16. Christian Happi
    17. Andrew Owen
    18. Adeniyi Olagunju
    This article has 1 evaluations Latest evaluation on Feb 8, 2022 Published on Feb 4, 2022
  • SARS-CoV-2 and influenza co-infection throughout the COVID-19 pandemic: An assessment of co-infection rates and cohort characterization

    This article's authors
    1. Colin Pawlowski
    2. Eli Silvert
    3. John C. O’Horo
    4. Patrick J. Lenehan
    5. Doug Challener
    6. Esteban Gnass
    7. Karthik Murugadoss
    8. Jason Ross
    9. Leigh Speicher
    10. Holly Geyer
    11. AJ Venkatakrishnan
    12. Andrew Badley
    13. Venky Soundararajan
    This article has 1 evaluations Latest evaluation on Feb 8, 2022 Published on Feb 5, 2022
  • OraSure InteliSwab ® Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and Omicron

    This article's authors
    1. Zachary A. Weishampel
    2. Janean Young
    3. Mark Fischl
    4. Robert J. Fischer
    5. Irene Owusu Donkor
    6. Jade C. Riopelle
    7. Jonathan E. Schulz
    8. Julia R. Port
    9. Taylor A. Saturday
    10. Neeltje van Doremalen
    11. Jody D. Berry
    12. Vincent J. Munster
    13. Claude Kwe Yinda
    This article has 1 evaluations Latest evaluation on Feb 7, 2022 Published on Feb 4, 2022
  • Transparency and reporting characteristics of COVID-19 randomized controlled trials

    This article's authors
    1. Philipp Kapp
    2. Laura Esmail
    3. Lina Ghosn
    4. Philippe Ravaud
    5. Isabelle Boutron
    This article has 1 evaluations Latest evaluation on Feb 7, 2022 Published on Feb 4, 2022
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information